investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Transgenic Models for Prostate and Breast Cancer
Jeffrey Green
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
To use genomic technologies to understand prostate and mammary cancer progression.
Related projects
Tina Hernandez-Boussard
Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care
Prostate
Song Yao
Exome Array Analysis of Reproductive Aging and Breast Cancer in African Americans
Breast
Alison Motsinger-Reif
Genetic Etiology of Cancer Drug Response
Breast
Yuet Ming Rebecca Chin
Akt isoform-specific signaling in breast cancer metastasis
Breast
Li Tang
Nutrigenetics of cruciferous vegetable intake and breast cancer prognosis
Breast
Peter Sicinski
Cyclin-Dependent Kinases in Oncogenesis
Breast
Suzanne A Fuqua
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
Breast
Alana L Welm
Short-form Ron Kinase in Tumor Progression and Metastasis
Breast
William J Murphy
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
Breast